Friulchem
On 23 July 2019, Friulchem S.p.A. obtained admission to negotiate ordinary shares on AIM Italia, a multilateral negotiations system organized and managed by Borsa Italiana. Negotiations began on 25 July 2019.
Integrae SIM acted as Nomad, Global Coordinator, Private Placement Bookrunner, and Specialist of the Issuer.
The total equivalent of the resources raised through the operation amounts to Euro 4.5 million, through the issuance of 2,499,750 newly issued shares without nominal value.
The placement price The unit price of the shares resulting from the placement was set at Euro 1.80; based on this price, the market capitalization at the beginning of the negotiations was equal to Euro 14.4 million.
The enterprise. Friulchem (AIM: FCM), active for over 20 years on the market, is today one of the main Italian CDMOs (Contract Development Manufacturing Organizations) active internationally in healthcare through the research and development and production on behalf of third parties of semi-finished and finished products containing both pharmaceutical active ingredients and food supplements, with particular specialization in so-called drug delivery systems for the veterinary sector that represents Friulchem’s excellence, and in the development of dossiers for generic drugs for the human sector. Friulchem is an innovative SME and B2B company with an appreciable propensity for the end client to have solid Italian roots thanks to the production plant in Vivaro (Pordenone) and the administrative headquarters in Milan. The Company, strongly oriented to R&D, boasts consolidated relationships with the main multinationals in the pharmaceutical sector.
Ultima Ricerca Friulchem
BREAKING NEWS| In its press release dated July 30, 2026, Siav SpA Società Benefit, Italy’s leading provider of Enterprise Content Management and Business Process Outsourcing solutions, announced the completion of the acquisition of 100.0% of the share capital of IT Consult S.r.l., an Italian software company specializing in proprietary solutions for document management, digital processes, and cloud services. The transaction was completed following the fulfillment of all contractual conditions precedent. The total consideration amounts to approximately € 3.40 million, structured as 60.0% in cash and 40.0% through a reserved capital increase. The cash consideration will be paid in three equal installments, each representing 20.0% of the purchase price: the first installment was paid at closing, while the remaining two will be settled by December 31, 2026, and March 31, 2027, respectively. The equity component was settled on the date of the announcement through the full subscription of the reserved capital increase allocated pro rata to the selling shareholders. The capital increase, approved by the Board of Directors on July 23, 2026, under the partial exercise of the authority granted by the Extraordinary Shareholders’ Meeting, involved the issuance of 480,984 new ordinary shares, with no nominal value, at a subscription price of € 2.81 per share, for a total value of approximately € 1.35 million. In addition, the agreement includes an earn-out mechanism of up to € 1.00 million, linked to the adjusted EBITDA achieved by IT Consult during the 2026 and 2027 financial years. Following the closing, the new Board of Directors of IT Consult consists of Nicola Voltan as Chairman, Giovanni Marrè as Chief Executive Officer, and Daniele Boggian as Director. From a strategic perspective, the acquisition is fully aligned with Siav’s external growth strategy and forms part of a broader organizational and managerial transformation. The integration of technological capabilities complementary to those already within the Group and the expansion of its product offering are expected to support future growth opportunities. Furthermore, the acquisition is intended to strengthen Siav’s positioning in strategically important markets, create new commercial opportunities, and enhance the quality and predictability of revenues, while ensuring business continuity and preserving the valuable know-how developed by IT Consult over the years. In light of the information disclosed in the press release, we confirm our recommendation: target price € 5.70, rating BUY, risk Medium. |
